Sodium-Glucose Cotransporter 2 Inhibitor-Associated “Ketoacidosis” Versus “Diabetic Ketoacidosis”: The Importance of Accurate Terminology

Tamara Y. Milder (), David A. Milder, Jerry R. Greenfield and Richard O. Day
Additional contact information
Tamara Y. Milder: St. Vincent’s Hospital
David A. Milder: UNSW Sydney
Jerry R. Greenfield: St. Vincent’s Hospital
Richard O. Day: St. Vincent’s Hospital

Drug Safety, 2023, vol. 46, issue 12, No 2, 1303-1305

Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-023-01358-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:46:y:2023:i:12:d:10.1007_s40264-023-01358-5

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-023-01358-5

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().